485 related articles for article (PubMed ID: 26377915)
21. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice.
Cohen SJ; Cohen IR; Nussbaum G
J Immunol; 2010 Jan; 184(1):212-21. PubMed ID: 19949074
[TBL] [Abstract][Full Text] [Related]
22. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
23. The role of CNS TLR2 activation in mediating innate versus adaptive neuroinflammation.
Luz A; Fainstein N; Einstein O; Ben-Hur T
Exp Neurol; 2015 Nov; 273():234-42. PubMed ID: 26342755
[TBL] [Abstract][Full Text] [Related]
24. The motorized RhoGAP myosin IXb (Myo9b) in leukocytes regulates experimental autoimmune encephalomyelitis induction and recovery.
Liu Z; Xu Y; Zhang X; Song J; Sorokin L; Bähler M
J Neuroimmunol; 2015 May; 282():25-32. PubMed ID: 25903725
[TBL] [Abstract][Full Text] [Related]
25. Spinal IL-36γ/IL-36R participates in the maintenance of chronic inflammatory pain through astroglial JNK pathway.
Li Q; Liu S; Li L; Ji X; Wang M; Zhou J
Glia; 2019 Mar; 67(3):438-451. PubMed ID: 30578562
[TBL] [Abstract][Full Text] [Related]
26. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
Xie C; Ciric B; Yu S; Zhang GX; Rostami A
J Neuroimmunol; 2016 Feb; 291():59-69. PubMed ID: 26857496
[TBL] [Abstract][Full Text] [Related]
27. Siglec-H is a microglia-specific marker that discriminates microglia from CNS-associated macrophages and CNS-infiltrating monocytes.
Konishi H; Kobayashi M; Kunisawa T; Imai K; Sayo A; Malissen B; Crocker PR; Sato K; Kiyama H
Glia; 2017 Dec; 65(12):1927-1943. PubMed ID: 28836308
[TBL] [Abstract][Full Text] [Related]
28. Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis.
Quintana A; Müller M; Frausto RF; Ramos R; Getts DR; Sanz E; Hofer MJ; Krauthausen M; King NJ; Hidalgo J; Campbell IL
J Immunol; 2009 Aug; 183(3):2079-88. PubMed ID: 19597000
[TBL] [Abstract][Full Text] [Related]
29. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
Lee E; Chanamara S; Pleasure D; Soulika AM
J Neuroinflammation; 2012 Jan; 9():7. PubMed ID: 22248039
[TBL] [Abstract][Full Text] [Related]
30. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of NADPH oxidase activation reduces EAE-induced white matter damage in mice.
Choi BY; Kim JH; Kho AR; Kim IY; Lee SH; Lee BE; Choi E; Sohn M; Stevenson M; Chung TN; Kauppinen TM; Suh SW
J Neuroinflammation; 2015 May; 12():104. PubMed ID: 26017142
[TBL] [Abstract][Full Text] [Related]
32. Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease.
Graham KL; Zabel BA; Loghavi S; Zuniga LA; Ho PP; Sobel RA; Butcher EC
J Immunol; 2009 Nov; 183(10):6717-23. PubMed ID: 19864606
[TBL] [Abstract][Full Text] [Related]
33. Knockout of the interleukin-36 receptor protects against renal ischemia-reperfusion injury by reduction of proinflammatory cytokines.
Nishikawa H; Taniguchi Y; Matsumoto T; Arima N; Masaki M; Shimamura Y; Inoue K; Horino T; Fujimoto S; Ohko K; Komatsu T; Udaka K; Sano S; Terada Y
Kidney Int; 2018 Mar; 93(3):599-614. PubMed ID: 29241623
[TBL] [Abstract][Full Text] [Related]
34. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
35. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis.
Becher B; Durell BG; Noelle RJ
J Clin Invest; 2003 Oct; 112(8):1186-91. PubMed ID: 14561703
[TBL] [Abstract][Full Text] [Related]
36. Pertussis toxin modulates microglia and T cell profile to protect experimental autoimmune encephalomyelitis.
Yin JX; Tang Z; Gan Y; Li L; Shi F; Coons S; Shi J
Neuropharmacology; 2014 Jun; 81():1-5. PubMed ID: 24486709
[TBL] [Abstract][Full Text] [Related]
37. T cell-independent modulation of experimental autoimmune encephalomyelitis in ADAP-deficient mice.
Engelmann S; Togni M; Thielitz A; Reichardt P; Kliche S; Reinhold D; Schraven B; Reinhold A
J Immunol; 2013 Nov; 191(10):4950-9. PubMed ID: 24101551
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system.
Toft-Hansen H; Babcock AA; Millward JM; Owens T
J Neuroinflammation; 2007 Sep; 4():24. PubMed ID: 17883829
[TBL] [Abstract][Full Text] [Related]
39. Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development.
Mimura LA; Chiuso-Minicucci F; Fraga-Silva TF; Zorzella-Pezavento SF; França TG; Ishikawa LL; Penitenti M; Ikoma MR; Sartori A
Neuroscience; 2016 Mar; 317():130-40. PubMed ID: 26762804
[TBL] [Abstract][Full Text] [Related]
40. Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
Theotokis P; Touloumi O; Lagoudaki R; Nousiopoulou E; Kesidou E; Siafis S; Tselios T; Lourbopoulos A; Karacostas D; Grigoriadis N; Simeonidou C
J Neuroinflammation; 2016 Oct; 13(1):265. PubMed ID: 27724971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]